Cargando…

Frequency of Cardiovascular Involvement in Familial Amyloidotic Polyneuropathy in Brazilian Patients

BACKGROUND: Familial amyloidotic polyneuropathy (FAP) is a rare disease diagnosed in Brazil and worldwide. The frequency of cardiovascular involvement in Brazilian FAP patients is unknown. OBJECTIVE: Detect the frequency of cardiovascular involvement and correlate the cardiovascular findings with th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Queiroz, Márcia Cavalcanti de Campos, Pedrosa, Roberto Coury, Berensztejn, Amanda Cardoso, Pereira, Basílio de Bragança, do Nascimento, Emília Matos, Duarte, Martha Maria Turano, Pereira-Junior, Pedro Paulo, Cruz, Marcia Waddington
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651409/ https://www.ncbi.nlm.nih.gov/pubmed/26351985 http://dx.doi.org/10.5935/abc.20150112

Ejemplares similares

Glial cells in familial amyloidotic polyneuropathy
por: Gonçalves, Nádia Pereira, et al.
Publicado: (2014)

Familial amyloidotic polyneuropathy in Crete, Greece
por: Tzagournissakis, Minas, et al.
Publicado: (2015)

Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
por: Suhr, Ole B, et al.
Publicado: (2015)

MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy
por: Martins, Diana, et al.
Publicado: (2017)

Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP)
por: Adams, David, et al.
Publicado: (2015)

Relationship between Fibrosis and Ventricular Arrhythmias in Chagas Heart Disease Without Ventricular Dysfunction
por: Tassi, Eduardo Marinho, et al.
Publicado: (2014)

Relação entre Norepinefrina Urinária, Fibrose e Arritmias na Cardiopatia Chagásica Crônica com Fração de Ejeção Preservada ou Minimamente Reduzida
por: Tassi, Eduardo Marinho, et al.
Publicado: (2022)

Late-onset Familial Amyloidotic Polyneuropathy with Bence Jones Proteinuria and Cardiomyopathy
por: García de León, Sira Carrasco, et al.
Publicado: (2017)

De novo intraocular amyloid deposition after hepatic transplantation in familial amyloidotic polyneuropathy
por: Gama, Ivo Filipe, et al.
Publicado: (2017)

Tissue remodeling after RNAi-mediated knockdown of TTR in a Familial Amyloidotic Polyneuropathy mouse model
por: Gonçalves, Nádia Pereira, et al.
Publicado: (2015)

Hereditary transthyretin-mediated amyloidosis with polyneuropathy: baseline anthropometric, demographic and disease characteristics of patients from a reference center
por: Sequeira, Vanessa Cristina Cunha, et al.
Publicado: (2021)

Transthyretin-related familial amyloidotic polyneuropathy—Progress in Kumamoto, Japan (1967–2010)—
por: ARAKI, Shukuro, et al.
Publicado: (2010)

Familial amyloidotic polyneuropathy: current and emerging treatment options for transthyretin-mediated amyloidosis
por: Hund, Ernst
Publicado: (2012)

Long-Term Outcomes and Complications of Trabeculectomy for Secondary Glaucoma in Patients with Familial Amyloidotic Polyneuropathy
por: Kawaji, Takahiro, et al.
Publicado: (2014)

The phenotypical expression of an European inherited TTR amyloidosis in Brazil
por: Cruz, Márcia Waddington, et al.
Publicado: (2015)

Familial amyloidotic polyneuropathy with muscle, vitreous, leptomeningeal, and cardiac involvement: Phenotypic, pathological, and MRI description
por: Prashantha, D. K., et al.
Publicado: (2010)

Beyond Genetic Factors in Familial Amyloidotic Polyneuropathy: Protein Glycation and the Loss of Fibrinogen's Chaperone Activity
por: da Costa, Gonçalo, et al.
Publicado: (2011)

Diflunisal compassive use in transthyretin familial amyloidotic polyneuropathy (TTR-FAP): report of the first Spanish experience
por: Contesse, Sebastián E Azorín, et al.
Publicado: (2015)

Familial amyloidotic polyneuropathy associated with the transthyretin CYS 114 gene in a Russian pair of monozygotic twins.
por: Igor, Igor Srokov, et al.
Publicado: (2015)

Accelerating restrictive cardiomyopathy after liver transplantation in a patient with familial amyloidotic polyneuropathy: a case report
por: Robin, Jason, et al.
Publicado: (2008)

Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD
por: Teixeira, Anabela C, et al.
Publicado: (2013)

Transscleral Cyclophotocoagulation in Familial Amyloidotic Polyneuropathy Secondary Glaucoma after Ahmed Valve Implantation: A Case Series Study
por: Vieira, Rita, et al.
Publicado: (2021)

Survival Probability in Patients with Sickle Cell Anemia Using the Competitive Risk Statistical Model
por: do Nascimento, Emilia Matos, et al.
Publicado: (2019)

Exercise through a cardiac rehabilitation program attenuates oxidative stress in patients submitted to coronary artery bypass grafting
por: Taty Zau, José Francisco, et al.
Publicado: (2017)

Teachings from the French database of TTR familial amyloidotic polyneuropathy (TTR-FAP): large genetic and phenotypic heterogeneity, usefulness of TTR gene testing.
por: Adams, David, et al.
Publicado: (2015)

Ocular Manifestations in a Chinese Pedigree of Familial Amyloidotic Polyneuropathy Carrying the Transthyretin Mutation c.401A>G (p.Tyr134Cys)
por: Zhuang, Xiaonan, et al.
Publicado: (2022)

Familial Amyloid Polyneuropathy Misdiagnosed as Systemic Sclerosis
por: Pereira, Márcia Agostinho, et al.
Publicado: (2022)

Model choice in nonnested families
por: Pereira, Basilio de Bragança, et al.
Publicado: (2016)

Inflammatory profiling of patients with familial amyloid polyneuropathy
por: Azevedo, Estefania P., et al.
Publicado: (2019)

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H., et al.
Publicado: (2018)

Risk Factors of Pulmonary Hypertension in Brazilian Patients with Sickle Cell Anemia
por: Lobo, Clarisse Lopes de Castro, et al.
Publicado: (2015)

Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration
por: Brunetti, Dario, et al.
Publicado: (2015)

Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy
por: Waddington Cruz, Márcia, et al.
Publicado: (2016)

Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy
por: Waddington-Cruz, Marcia, et al.
Publicado: (2015)

Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years
por: Merlini, Giampaolo, et al.
Publicado: (2020)

Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Waddington‐Cruz, Márcia, et al.
Publicado: (2021)

Synergistic Effect of Disease Severity, Anxiety Symptoms and Elderly Age on the Quality of Life of Outpatients with Heart Failure
por: Figueiredo, José Henrique Cunha, et al.
Publicado: (2020)

Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series
por: Waddington-Cruz, Márcia, et al.
Publicado: (2019)

Survival and Predictive Factors of Lethality in Hemodyalisis: D/I Polymorphism of The Angiotensin I-Converting Enzyme and of the Angiotensinogen M235T Genes
por: Alves, Mauro, et al.
Publicado: (2014)

Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
por: Chu, Jin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4ofokihqhonp1gr0dkjcsalsns